Daiichi Sankyo SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Daiichi Sankyo analyses the brand by its strengths, weaknesses, opportunities & threats. In Daiichi Sankyo SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Daiichi Sankyo to benchmark its business & performance as compared to the competitors. Daiichi Sankyo is one of the leading brands in the pharma and healthcare sector.

The table below lists the Daiichi Sankyo SWOT (Strengths, Weaknesses, Opportunities, Threats), top Daiichi Sankyo competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

Daiichi Sankyo SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Daiichi Sankyo Brand Analysis
Parent Company

Daiichi Sankyo

Category

Pharmaceutical

Sector

Pharma and Healthcare

Tagline/ Slogan

Passion for innovation, Compassion for patients

USP

It is one of the largest pharmaceutical company in Japan

Daiichi Sankyo STP
Segment

Oncology & Cardiovascular diseases

Target Group

Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease

Positioning

They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time

SWOT Analysis of Daiichi Sankyo
Daiichi Sankyo Strengths

Below are the Strengths in the SWOT Analysis of Daiichi Sankyo:

1. Has a strong workforce of over 30,000 employees

2. Leading producer of Benicar which is angiotensin II receptor antagonist

3. It is one of the largest pharmaceutical company in Japan

4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others
5. Strong brand establishment through many major acquisitions

Daiichi Sankyo Weaknesses

Here are the weaknesses in the Daiichi Sankyo SWOT Analysis:

1. Despite being a strong brand, had a limited market share due to international competitors

2. Operates in limited segments such as Oncology & Cardiovascular segment

Daiichi Sankyo Opportunities

Following are the Opportunities in Daiichi Sankyo SWOT Analysis:

1. Increasing world population and more awareness about health

2. More people suffering from chronic diseases such as cancer, cardiovascular diseases

3. Increasing awareness of healthcare solutions

Daiichi Sankyo Threats

The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned:

1. Natural disasters in Japan

2. increasing stringency in drug development guidelines

3. Global economic slowdown

Daiichi Sankyo Competition
Daiichi Sankyo Competitors

Below are the top 4 competitors of Daiichi Sankyo:

1. Takeda Pharmaceuticals
2. Teva pharmaceuticals

3. Astellas pharmaceuticals

4. AstraZeneca


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:


The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin